Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
Conditions: Schizophrenia; Psychotic Disorders; Psychosis Interventions: Drug: Aripiprazole; Drug: Risperidone Sponsors: Fundación Marques de Valdecilla; Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación Marqués de Valdecilla Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2019 Category: Research Source Type: clinical trials
DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole
Conditions: Schizophrenia; Major Depressive Disorder; Bi-Polar Disorder; Schizo Affective Disorder Intervention: Combination Product: ABILIFY MYCITE Sponsors: Durham VA Medical Center; Otsuka Pharmaceutical Development and Commercialization, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2019 Category: Research Source Type: clinical trials